| 1 |
-
Connecting sugar and fibrosis: Diabetes as a hidden player in rheumatoid arthritis-associated interstitial lung disease
-
1/5/2026 6:55:13 AM | Browse: 35 | Download: 46
|
| 2 |
-
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
-
12/26/2025 10:27:34 AM | Browse: 37 | Download: 114
|
| 3 |
-
Impact of age on autoimmune hepatitis: A comparative study of patients diagnosed before and after sixty
-
12/26/2025 10:27:33 AM | Browse: 27 | Download: 141
|
| 4 |
-
Gut microbiota-derived trimethylamine N-oxide exacerbates diabetic nephropathy by promoting renal fibrosis
-
12/23/2025 8:03:26 AM | Browse: 25 | Download: 94
|
| 5 |
-
Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease
-
12/19/2025 10:39:41 AM | Browse: 26 | Download: 110
|
| 6 |
-
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy
-
12/15/2025 9:46:06 AM | Browse: 31 | Download: 65
|
| 7 |
-
Beyond bones: Revisiting the role of vitamin D in chronic liver disease
-
11/27/2025 7:53:57 AM | Browse: 26 | Download: 62
|
| 8 |
-
Endoscopic retrograde cholangiopancreatography for the management of biliary fistula following liver hydatid cyst related surgery or radiological interventions
-
11/25/2025 11:05:37 AM | Browse: 24 | Download: 92
|
| 9 |
-
Hepatoprotective effects of silybin in liver fibrosis
-
11/13/2025 6:51:09 AM | Browse: 46 | Download: 126
|
| 10 |
-
Immunoglobulin G4-related disease requiring clinical attention: A case report and review of literature
-
10/14/2025 7:41:42 AM | Browse: 33 | Download: 148
|
| 11 |
-
Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation
-
9/25/2025 11:24:01 AM | Browse: 98 | Download: 131
|
| 12 |
-
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations
-
9/25/2025 3:33:09 AM | Browse: 116 | Download: 128
|
| 13 |
-
HOX and MEINOX in cellular plasticity, fibrosis, and cancer
-
9/24/2025 3:48:37 AM | Browse: 52 | Download: 170
|
| 14 |
-
Critical flicker frequency improves after alcohol detoxification and is associated with liver stiffness
-
9/19/2025 7:57:22 AM | Browse: 339 | Download: 116
|
| 15 |
-
Estimation of pancreatic histology and likelihood of postoperative pancreatic fistula using extracellular volume fraction from contrast-enhanced computed tomography
-
8/5/2025 8:58:37 AM | Browse: 83 | Download: 289
|
| 16 |
-
Diagnostic performance of Liver FibraChek Dx©, a blood-based test for the non-invasive detection of liver cirrhosis and cancer
-
6/26/2025 7:27:58 AM | Browse: 89 | Download: 422
|
| 17 |
-
Pathophysiology of anastomotic stricture following rectal anastomosis: Insights into mechanisms, risk factors, and preventive strategies
-
6/19/2025 8:18:36 AM | Browse: 44 | Download: 132
|
| 18 |
-
Advances in neutrophil extracellular trap formation in osteoarticular diseases
-
5/16/2025 7:21:10 AM | Browse: 172 | Download: 383
|
| 19 |
-
Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference
-
3/26/2025 4:06:57 AM | Browse: 92 | Download: 514
|
| 20 |
-
MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage
-
2/28/2025 10:45:44 AM | Browse: 107 | Download: 722
|
| 21 |
-
NR4A1 silencing alleviates high-glucose-stimulated HK-2 cells pyroptosis and fibrosis via hindering NLRP3 activation and PI3K/AKT pathway
-
1/21/2025 9:26:52 AM | Browse: 136 | Download: 704
|
| 22 |
-
Prospects of elafibranor in treating alcohol-associated liver diseases
-
12/18/2024 7:36:02 AM | Browse: 108 | Download: 447
|
| 23 |
-
Kangfuxin solution alleviates esophageal stenosis after endoscopic submucosal dissection: A natural ingredient strategy
-
12/9/2024 10:40:10 AM | Browse: 89 | Download: 526
|
| 24 |
-
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
-
10/25/2024 3:02:15 AM | Browse: 164 | Download: 605
|
| 25 |
-
Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
-
10/21/2024 7:03:25 AM | Browse: 95 | Download: 540
|
| 26 |
-
Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
-
9/26/2024 8:22:29 AM | Browse: 127 | Download: 473
|
| 27 |
-
Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
-
7/26/2024 10:33:29 AM | Browse: 165 | Download: 651
|
| 28 |
-
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
-
7/25/2024 7:15:47 AM | Browse: 162 | Download: 559
|
| 29 |
-
Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications
-
7/11/2024 8:47:17 AM | Browse: 179 | Download: 512
|
| 30 |
-
New markers of fibrosis in hepatitis C: A step towards the Holy Grail?
-
2/27/2024 11:58:45 AM | Browse: 141 | Download: 573
|
| 31 |
-
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
-
11/24/2023 6:10:12 AM | Browse: 278 | Download: 1232
|
| 32 |
-
Sclerotic marginal zone lymphoma: A case report
-
9/20/2023 7:36:10 AM | Browse: 272 | Download: 735
|
| 33 |
-
Evaluation of the nutritional status of patients with liver cirrhosis
-
7/21/2023 9:10:50 AM | Browse: 382 | Download: 1225
|
| 34 |
-
Stromal inflammation, fibrosis and cancer: An old intuition with promising potential
-
7/19/2023 6:45:14 AM | Browse: 512 | Download: 1096
|
| 35 |
-
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
-
5/24/2023 9:31:05 AM | Browse: 394 | Download: 1182
|
| 36 |
-
Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis
-
2/24/2023 1:35:50 PM | Browse: 294 | Download: 850
|
| 37 |
-
Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
-
2/24/2023 1:35:50 PM | Browse: 474 | Download: 1084
|
| 38 |
-
Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report
-
10/25/2022 11:36:14 AM | Browse: 607 | Download: 1565
|
| 39 |
-
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
-
8/26/2022 9:51:35 AM | Browse: 601 | Download: 1325
|
| 40 |
-
Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis
-
8/26/2022 7:50:06 AM | Browse: 538 | Download: 1321
|
| 41 |
-
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
-
7/18/2022 9:47:46 AM | Browse: 724 | Download: 2586
|
| 42 |
-
Anabolic androgenic steroid-induced liver injury: An update
-
7/13/2022 7:30:59 AM | Browse: 814 | Download: 1403
|
| 43 |
-
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
-
4/30/2022 5:08:22 AM | Browse: 633 | Download: 1876
|
| 44 |
-
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
-
4/29/2022 11:12:04 AM | Browse: 681 | Download: 1304
|
| 45 |
-
Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis
-
3/11/2022 9:47:59 AM | Browse: 691 | Download: 1666
|
| 46 |
-
Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
-
2/25/2022 12:19:16 PM | Browse: 714 | Download: 1612
|
| 47 |
-
Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
-
1/21/2022 8:16:14 AM | Browse: 669 | Download: 1727
|
| 48 |
-
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
-
12/27/2021 5:24:00 AM | Browse: 599 | Download: 1660
|
| 49 |
-
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
-
12/27/2021 5:24:00 AM | Browse: 689 | Download: 1458
|
| 50 |
-
Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model
-
12/17/2021 8:56:01 AM | Browse: 793 | Download: 2228
|
